Catharina Larsson

22.3k total citations · 2 hit papers
358 papers, 14.4k citations indexed

About

Catharina Larsson is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Catharina Larsson has authored 358 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Molecular Biology, 88 papers in Oncology and 87 papers in Genetics. Recurrent topics in Catharina Larsson's work include Neuroendocrine Tumor Research Advances (68 papers), Thyroid Cancer Diagnosis and Treatment (44 papers) and Cancer, Hypoxia, and Metabolism (41 papers). Catharina Larsson is often cited by papers focused on Neuroendocrine Tumor Research Advances (68 papers), Thyroid Cancer Diagnosis and Treatment (44 papers) and Cancer, Hypoxia, and Metabolism (41 papers). Catharina Larsson collaborates with scholars based in Sweden, United States and Australia. Catharina Larsson's co-authors include Anders Höög, Magnus Nordenskjöld, Jan Zedenius, Britt Skogseid, Weng‐Onn Lui, Kjell Öberg, Bin Tean Teh, C. Christofer Juhlin, Martin Bäckdahl and Dawei Xu and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Catharina Larsson

352 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma

1988 794 citations Catharina Larsson, Magnus Nordenskjöld et al. profile →
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players

2019 302 citations Xiaotian Yuan, Catharina Larsson et al. profile →

Peers

Countries citing papers authored by Catharina Larsson

Since Specialization

Citations

This map shows the geographic impact of Catharina Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catharina Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catharina Larsson more than expected).

Fields of papers citing papers by Catharina Larsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catharina Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catharina Larsson. The network helps show where Catharina Larsson may publish in the future.

Co-authorship network of co-authors of Catharina Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Catharina Larsson. A scholar is included among the top collaborators of Catharina Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catharina Larsson. Catharina Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice 2024 ·Endocrine Pathology ·(unknown), Adam Stenman, Kenbugul Jatta, Vincenzo Condello, Catharina Larsson, Jan Zedenius, C. Christofer Juhlin	2
2	Genetic variants and down-regulation of CACNA1H in pheochromocytoma 2024 ·Endocrine Related Cancer ·Fredrika Svahn, (unknown), Adam Stenman, (unknown), Jan Calissendorff, Emma Tham, Ákos Végvári, Roman A. Zubarev, (unknown), Reju Korah, Tobias Carling, Jan Zedenius, Robert Bränström, C. Christofer Juhlin, Catharina Larsson	1
3	Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival 2024 ·ESMO Open ·(unknown), C. Christofer Juhlin, Tobias Carling, Ute I. Scholl, M. Schott, Catharina Larsson, Svetlana Bajalica‐Lagercrantz	5
4	Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer 2022 ·Biomedicines ·(unknown), Hafdís T. Helgadóttir, Pedram Kharaziha, Jungmin Choi, Francesc López‐Giráldez, Shrikant Mane, Veronica Höiom, C. Christofer Juhlin, Catharina Larsson, Svetlana Bajalica‐Lagercrantz	1
5	Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features 2022 ·Cancers ·(unknown), Ninni Mu, Xiaotian Yuan, Na Wang, C. Christofer Juhlin, Klas Strååt, Catharina Larsson, Shiyong Neo, Dawei Xu	7
6	Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Robert Konrat, Pedram Kharaziha, Catharina Larsson, Anthony P. H. Wright, Svetlana Bajalica‐Lagercrantz	4
7	Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70 2021 ·iScience ·Jiwei Gao, (unknown), C. Christofer Juhlin, Catharina Larsson, Weng‐Onn Lui	3
8	Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors 2021 ·Nucleic Acids Research ·Shi Yao, Juan Yuan, Vilma Rraklli, (unknown), Miriam Cipullo, Mingzhi Liu, Shuijie Li, Isabelle Westerlund, Oscar C. Bedoya-Reina, Petra Bullova, Joanna Rorbach, C. Christofer Juhlin, Adam Stenman, Catharina Larsson, Per Kogner, Maureen J. O’Sullivan, Susanne Schlisio, Johan Holmberg	10
9	Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors 2021 ·International Journal of Molecular Sciences ·Wen‐Kuan Huang, (unknown), Pınar Akçakaya, Katarina Zeljić, Anastasia Gangaev, Stefano Caramuta, Chun‐Nan Yeh, Robert Bränström, Catharina Larsson, Weng‐Onn Lui	7
10	Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor 2020 ·Cells ·Wen‐Kuan Huang, Jiwei Gao, Ziqing Chen, (unknown), Juan Yuan, Huanhuan Cui, Chun‐Nan Yeh, Robert Bränström, Catharina Larsson, (unknown), Weng‐Onn Lui	17
11	PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma 2020 ·Cancers ·(unknown), Ninni Mu, Xiaotian Yuan, Na Wang, C. Christofer Juhlin, Klas Strååt, Catharina Larsson, Dawei Xu	16
12	Activation of RAS Signalling is Associated with Altered Cell Adhesion in Phaeochromocytoma 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), Catharina Larsson, Hans K. Ghayee, Peter Söderkvist, Oliver Gimm	5
13	Functional characterization of novel germline TP53 variants in Swedish families 2019 ·Clinical Genetics ·Pedram Kharaziha, Sophia Ceder, (unknown), (unknown), (unknown), Stefanie Böhm, Sonia Laı́n, Åke Borg, Catharina Larsson, Klas G. Wiman, Emma Tham, Svetlana Bajalica‐Lagercrantz	9
14	High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma 2018 ·Endocrine ·Ninni Mu, C. Christofer Juhlin, Edneia Tani, Anastasios Sofiadis, Eva Reihnér, Jan Zedenius, Catharina Larsson, Inga‐Lena Nilsson	20
15	A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis 2017 ·BMC Cancer ·J Cheng, T Brown, Timothy D. Murtha, Adam Stenman, C. Christofer Juhlin, Catharina Larsson, James M. Healy, Manju L. Prasad, Wolfram Trudo Knoefel, Andreas Krieg, Ute I. Scholl, Reju Korah, Tobias Carling	12
16	Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell–Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells 2014 ·Clinical Cancer Research ·Erik Wennerberg, Aline Pfefferle, Lars Ekblad, Yuya Yoshimoto, Veronika Kremer, Vitaliy O. Kaminskyy, C. Christofer Juhlin, Anders Höög, Inger Bodin, (unknown), Catharina Larsson, Jan Zedenius, Johan Wennerberg, Andreas Lundqvist	50
17	Global and Regional CpG Methylation in Pheochromocytomas and Abdominal Paragangliomas: Association to Malignant Behavior 2008 ·Clinical Cancer Research ·Janos Geli, Nimrod Kiss, Mohsen Karimi, (unknown), Martin Bäckdahl, Tomas J. Ekström, Catharina Larsson	47
18	CREB3L2-PPARγ Fusion Mutation Identifies a Thyroid Signaling Pathway Regulated by Intramembrane Proteolysis 2008 ·Cancer Research ·Weng‐Onn Lui, Lingchun Zeng, (unknown), Seema S. Deshpande, Maria Tretiakova, Edwin L. Kaplan, Ingo B. Leibiger, Barbara Leibiger, Ulla Enberg, Anders Höög, Catharina Larsson, Todd G. Kroll	51
19	Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? 1996 ·The Journal of Clinical Endocrinology & Metabolism ·Cornelia Dotzenrath, Bin Tean Teh, Filip Farnebo, Kenko Cupisti, Ann Svensson, Andrea Toell, (unknown), Catharina Larsson	66
20	Predisposition for breast cancer in carriers of constitutional translocation 11q;22q. 1994 ·PubMed ·Annika Lindblom, Kerstin Sandelin, Lennart Iselius, Jan P. Dumanski, I. White, Magnus Nordenskjöld, Catharina Larsson	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact